Search Results - Maria Reig

Systemic therapies in hepatocellular carcinoma: A revolution? by Marta Fortuny, Marco Sanduzzi‐Zamparelli, Maria Reig

Get full text

The ‘BCLC upon progression’ classification: After repeated validation, it is time to incorporate it in trial design by Manuel de la Torre‐Aláez, Maria Reig

Get full text

Association of Epigenetic Aging Biomarkers With Risk of MASLD ‐Related HCC by Alani Perkin, Sebastian M. Armasu, Winnie Z. Fan, Naana N. Yalley, Irene K. Yan, Fowsiyo Y. Ahmed, Laura Izquierdo‐Sanchez, Loreto Boix, Angela Rojas, Jesus M. Banales, Maria Reig, Per Stål, Manuel Romero Gómez, Amit G. Singal, Lewis R. Roberts, Kirk J. Wangensteen, Anders Berglund, Tushar Patel, Samuel O. Antwi

Get full text

Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second‐Line (The GOING Trial) by Marco Sanduzzi‐Zamparelli, Ana Matilla, José Luis Lledo, Sergio Muñoz‐Martínez, María Varela, Mercedes Iñarrairaegui, Christie Perelló, Beatriz Mínguez, Neus Llarch, Laura Márquez, Antonio Guerrero, Gemma Iserte, Andrés Castaño‐García, Laura Carrión, Marta Fortuny, Jordi Rimola, Ángeles García‐Criado, Gema Domenech, Ferran Torres, José Rios‐Guillermo, Loreto Boix, Esther Samper, Àngels Kateb, Jordi Bruix, Maria Reig

Get full text

Breaking Barriers for Intensive Care Admission in Patients With Advanced HCC on Immunotherapy by Marta Fortuny, Leonardo G. da Fonseca, Manon Allaire, Rocío Sánchez, Jean‐Charles Nault, Massimo Iavarone, Sofia Ridolfo, Sonia Pascual, Raquel Jimeno, Mariona Calvo, Raimon Rifà, Marco Sanduzzi‐Zamparelli, Natalia Jiménez‐Esquivel, Sarah Mouri, Mercedes Iñarrairaegui, Josepmaria Argemi, Tania Hernaez, José Enrique Lorenzo‐Barreto, María Teresa Ferrer, Susana Coll, Ángela Lamarca, Juan Ignacio Marin, Enric Reverter, Ana María López, Alberto Lue, María Varela, Ana Matilla, Javier Fernández, Maria Reig

Get full text